Earl Lewis
CIK: 0001230427
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TECOGEN INC.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 26, 2026TGEN
TECOGEN INC.
Award(A)DirectStock Option (Right to Buy)
25K shares at avg. $5.17- - Mar 27, 2026TGEN
TECOGEN INC.
Purchase(P)Direct5K shares at avg. $2.52$13K - Mar 26, 2026TGEN
TECOGEN INC.
Purchase(P)Direct5K shares at avg. $2.88$14K - Jul 24, 2025TGEN
TECOGEN INC.
Award(A)DirectStock Option (Right to Buy)
25K shares at avg. $8.35- - May 6, 2025TGEN
TECOGEN INC.
In-the-Money(X)Direct15K shares at avg. $1.75$26K - May 6, 2025TGEN
TECOGEN INC.
In-the-Money(X)Direct6.3K shares at avg. $1.10$7K - May 6, 2025TGEN
TECOGEN INC.
In-the-Money(X)Direct12.5K shares at avg. $1.20$15K - May 1, 2025TGEN
TECOGEN INC.
Other(J)Direct240.3K shares at avg. $2.14$514K - Nov 22, 2024TGEN
TECOGEN INC.
Exercise(M)DirectStock Option (Right to Buy)
100K shares at avg. $0.71- - Nov 22, 2024TGEN
TECOGEN INC.
In-the-Money(X)Direct100K shares at avg. $0.71$71K - Nov 22, 2024TGEN
TECOGEN INC.
Purchase(P)Direct100K shares at avg. $0.71$71K - Jul 15, 2024TGEN
TECOGEN INC.
Purchase(P)Direct10K shares at avg. $0.68$7K - Oct 9, 2023TGEN
TECOGEN INC.
Purchase(P)Direct2K shares at avg. $0.80$2K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2026 | TGEN TECOGEN INC. | Award(A) Stock Option (Right to Buy) | 25,000 | $5.17 | - | Direct |
| Mar 27, 2026 | TGEN TECOGEN INC. | Purchase(P) | 5,000 | $2.52 | $12,596 | Direct |
| Mar 26, 2026 | TGEN TECOGEN INC. | Purchase(P) | 5,000 | $2.88 | $14,409 | Direct |
| Jul 24, 2025 | TGEN TECOGEN INC. | Award(A) Stock Option (Right to Buy) | 25,000 | $8.35 | - | Direct |
| May 6, 2025 | TGEN TECOGEN INC. | In-the-Money(X) | 15,000 | $1.75 | $26,250 | Direct |
| May 6, 2025 | TGEN TECOGEN INC. | In-the-Money(X) | 6,250 | $1.10 | $6,875 | Direct |
| May 6, 2025 | TGEN TECOGEN INC. | In-the-Money(X) | 12,500 | $1.20 | $15,000 | Direct |
| May 1, 2025 | TGEN TECOGEN INC. | Other(J) | 240,256 | $2.14 | $514,148 | Direct |
| Nov 22, 2024 | TGEN TECOGEN INC. | Exercise(M) Stock Option (Right to Buy) | 100,000 | $0.71 | - | Direct |
| Nov 22, 2024 | TGEN TECOGEN INC. | In-the-Money(X) | 100,000 | $0.71 | $71,000 | Direct |
| Nov 22, 2024 | TGEN TECOGEN INC. | Purchase(P) | 100,000 | $0.71 | $71,000 | Direct |
| Jul 15, 2024 | TGEN TECOGEN INC. | Purchase(P) | 10,000 | $0.68 | $6,800 | Direct |
| Oct 9, 2023 | TGEN TECOGEN INC. | Purchase(P) | 2,000 | $0.80 | $1,600 | Direct |
1-13 of 13 transactions
About Lewis Earl
Lewis Earl (SEC CIK 0001230427) files insider reports with the SEC as Director of TECOGEN INC. (TGEN).
Signal8 holds 11 ownership filings by Lewis Earl, all Form 4s, filed between Dec 6, 2024 and Jun 30, 2026. Those filings report 13 transactions, from Oct 9, 2023 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lewis Earl's filings is in NORTH BILLERICA, MA.
Recent filings by Lewis Earl
- Jun 26, 2026: Grant or award of TGEN derivative securities (Form 4, code A).
- Mar 27, 2026: Open-market purchase of TGEN shares (Form 4, code P).
- Mar 26, 2026: Open-market purchase of TGEN shares (Form 4, code P).
- Jul 24, 2025: Grant or award of TGEN derivative securities (Form 4, code A).
- May 6, 2025: Option exercises of TGEN shares (3 lines, Form 4, code X).
Other insiders filing for TECOGEN INC. (TGEN)
- Lafaille Stephen, VP of Business Development
- Whiting John Kimball IV, General Counsel & Secretary
- Panora Robert, COO and President
- Deschenes Roger P., Chief Financial Officer
- Rangesh Abinand, Chief Executive Officer
- Hirsch Susan B, Director